Molecular Mechanisms for Biliary Phospholipid and Drug Efflux Mediated by ABCB4 and Bile Salts

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Morita, Shin Ya ^a   Terada, Tomohiro ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BILE SALT; FLUORESCENT DYE; MULTIDRUG RESISTANCE PROTEIN 3; PHOSPHOLIPID; BILE ACID; DRUG; MULTIDRUG RESISTANCE PROTEIN;

CELLULAR DISTRIBUTION; HUMAN; HYDROLYSIS; MOLECULAR BIOLOGY; MOLECULAR MODEL; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PROTEIN FUNCTION; REVIEW; AMINO ACID SEQUENCE; ANIMAL; BILE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; TRANSPORT AT THE CELLULAR LEVEL;

AMINO ACID SEQUENCE; ANIMALS; BILE; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; HUMANS; MOLECULAR SEQUENCE DATA; P-GLYCOPROTEINS; PHARMACEUTICAL PREPARATIONS; PHOSPHOLIPIDS;

EID: 84935882341     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/954781     Document Type: Review

References (65)

1. A. M. van der Bliek, P. M. Bliek, C. Schneider et al., "Sequence of mdr3 cDNA encoding a human P-glycoprotein, " Gene, vol. 71, no. 2, pp. 401-411, 1988.
2. C. R. Lincke, J. J. M. Smit, T. van der Velde-Koerts, and P. Borst, "Structure of the human MDR3 gene and physical mapping of the human MDR locus, " Journal of Biological Chemistry, vol. 266, no. 8, pp. 5303-5310, 1991.
3. M. M. Gottesman, T. Fojo, and S. E. Bates, "Multidrug resistance in cancer: role of ATP-dependent transporters, " Nature Reviews Cancer, vol. 2, no. 1, pp. 48-58, 2002.
4. R. P. J. Oude Elferink and C. C. Paulusma, "Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein), " Pflugers Archiv European Journal of Physiology, vol. 453, no. 5, pp. 601-610, 2007.
5. A. H. Schinkel, M. E. M. Roelofs, and P. Borst, "Characterization of the human MDR3 P-glycoprotein and its recognition by Pglycoprotein- specific monoclonal antibodies, " Cancer Research, vol. 51, no. 10, pp. 2628-2635, 1991.
6. R. L. Juliano and V. Ling, "A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants, " Biochimica et Biophysica Acta, vol. 455, no. 1, pp. 152-162, 1976.
7. I. B. Roninson, J. E. Chin, K. Choi et al., "Isolation of humanmdr DNA sequences amplified inmultidrug-resistant KB carcinoma cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 12, pp. 4538-4542, 1986.
8. K. Ueda, M. M. Cornwell, M. M. Gottesman et al., "The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein, " Biochemical and Biophysical Research Communications, vol. 141, no. 3, pp. 956-962, 1986.
9. K. Ueda, C. Cardarelli, M. M. Gottesman, and T. Pastan, "Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin, and vinblastine, " Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 9, pp. 3004-3008, 1987.
10. A. M. van der Bliek, F. Baas, T. TenHoute de Lange, P. M. Kooiman, T. van der Velde-Koerts, and P. Borst, "The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively splicedmRNAs in liver, "The EMBO Journal, vol. 6, no. 11, pp. 3325-3331, 1987.
11. A. Moschetta, G. P. VanBerge-Henegouwen, P. Portincasa, G. Palasciano, A. K. Groen, and K. J. van Erpecum, "Sphingomyelin exhibits greatly enhanced protection compared with egg yolk phosphatidylcholine against detergent bile salts, " Journal of Lipid Research, vol. 41, no. 6, pp. 916-924, 2000.
12. J. A. Higgins and W. H. Evans, "Transverse organization of phospholipids across the bilayer of plasma-membrane subfractions of rat hepatocytes, " Biochemical Journal, vol. 174, no. 2, pp. 563-567, 1978.
13. D. Alvaro, A. Cantafora, A. F. Attili et al., "Follicular cysts, odontogenic keratocysts, and gorlin-goltz syndrome: some clinicopathologic aspects, " Comparative Biochemistry and Physiology B: Biochemistry, vol. 83, no. 3, pp. 551-554, 1986.
14. J. J. M. Smit, A. H. Schinkel, R. P. J. Oude Elferink et al., "Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease, " Cell, vol. 75, no. 3, pp. 451-462, 1993.
15. F. Lammert, D. Q.-H. Wang, S. Hillebrandt et al., "Spontaneous cholecysto- and hepatolithiasis inMdr2-/-mice:amodel for low phospholipid-associated cholelithiasis, " Hepatology, vol. 39, no. 1, pp. 117-128, 2004.
16. R. P. J. Oude Elferink, R. Ottenhoff, M. van Wijland , J. J. M. Smit, A. H. Schinkel, and A. K. Groen, "Regulation of biliary lipid secretion bymdr2 P-glycoprotein in the mouse, " Journal of Clinical Investigation, vol. 95, no. 1, pp. 31-38, 1995.
17. R. P. J. Oude Elferink, R. Ottenhoff, M. van Wijland , C. M. G. Frijters, C. van Nieuwkerk, and A. K. Groen, "Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein, " Journal of Lipid Research, vol. 37, no. 5, pp. 1065-1075, 1996.
18. M. C. Carey and D. M. Small, "The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution inman, " Journal of Clinical Investigation, vol. 61, no. 4, pp. 998-1026, 1978.
19. E. Jacquemin, J. M. DeVree, D. Cresteil et al., "The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood, " Gastroenterology, vol. 120, no. 6, pp. 1448-1458, 2001.
20. J. Deleuze, E. Jacquemin, C. Dubuisson et al., "Defect of multidrug- resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis, " Hepatology, vol. 23, no. 4, pp. 904-908, 1996.
21. J. M. L. de Vree, E. Jacquemin, E. Sturm et al., "Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 1, pp. 282-287, 1998.
22. J. Lucena, J. I. Herrero, J. Quiroga et al., "A multidrug resistance 3 genemutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis, " Gastroenterology, vol. 124, no. 4, pp. 1037-1042, 2003.
23. O. Rosmorduc, B. Hermelin, P. Boelle, R. Parc, J. Taboury, and R. Poupon, "ABCB4 gene mutation-associated cholelithiasis in adults, " Gastroenterology, vol. 125, no. 2, pp. 452-459, 2003.
24. D. Tougeron, G. Fotsing, V. Barbu, and M. Beauchant, "ABCB4/ MDR3 gene mutations and cholangiocarcinomas, " Journal of Hepatology, vol. 57, no. 2, pp. 467-468, 2012.
25. M. Arrese and M. Ananthanarayanan, "The bile salt export pump: molecular properties, function and regulation, " Pflugers Archiv European Journal of Physiology, vol. 449, no. 2, pp. 123-131, 2004.
26. L. Yu, J. Li-Hawkins, R. E. Hammer et al., "Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol, " Journal of Clinical Investigation, vol. 110, no. 5, pp. 671-680, 2002.
27. L. Yu, R. E. Hammer, J. Li-Hawkins et al., "Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion, " Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 25, pp. 16237-16242, 2002.
28. D. M. Small, "Role of ABC transporters in secretion of cholesterol from liver into bile, " Proceedings of the National Academy of Sciences of theUnited States of America, vol. 100, no. 1, pp. 4-6, 2003.
29. T. Plösch, J. N. van der Veen, R. Havinga, N. C. A. Huijkman, V. W. Bloks, and F. Kuipers, "Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice, " The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 291, no. 3, pp. G414-G423, 2006.
30. S. Langheim, L. Yu, K. von Bergmann et al., "ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile, " Journal of Lipid Research, vol. 46, no. 8, pp. 1732-1738, 2005.
31. M. Pennings, R. B. Hildebrand , D. Ye et al., "Bone marrowderived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice, " Cardiovascular Research, vol. 76, no. 1, pp. 175-183, 2007.
32. S. Ruetz and P. Gros, "Phosphatidylcholine translocase: a physiological role for the mdr2 gene, " Cell, vol. 77, no. 7, pp. 1071-1081, 1994.
33. S. Ruetz and P. Gros, "Enhancement of Mdr2-mediated phosphatidylcholine translocation by the bile salt taurocholate. Implications for hepatic bile formation, " Journal of Biological Chemistry, vol. 270, no. 43, pp. 25388-25395, 1995.
34. A. Van Helvoort, A. J. Smith, H. Sprong et al., "MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine, " Cell, vol. 87, no. 3, pp. 507-517, 1996.
35. A. J. Smith, A. van Helvoort, G. van Meer et al., "MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drags as judged by interference with nucleotide trapping, " Journal of Biological Chemistry, vol. 275, no. 31, pp. 23530-23539, 2000.
36. J. Shoda, Y. Inada, A. Tsuji et al., "Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARα-mediated redistribution of ABCB4, " Journal of Lipid Research, vol. 45, no. 10, pp. 1813-1825, 2004.
37. N. S. Ghonem, M. Ananthanarayanan, C. J. Soroka, and J. L. Boyer, "Peroxisome proliferator-activated receptor alpha activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion, " Hepatology, vol. 59, no. 3, pp. 1030-1042, 2014.
38. S. Morita, A. Kobayashi, Y. Takanezawa et al., "Bile saltdependent efflux of cellular phospholipids mediated by ATP binding cassette protein B4, " Hepatology, vol. 46, no. 1, pp. 188-199, 2007.
39. D. M. Heuman, "Quantitative estimation of the hydrophilichydrophobic balance of mixed bile salt solutions, " Journal of Lipid Research, vol. 30, no. 5, pp. 719-730, 1989.
40. S. Morita, A. Takeuchi, and S. Kitagawa, "Functional analysis of two isoforms of phosphatidylethanolamine N-methyltransferase, " Biochemical Journal, vol. 432, no. 2, pp. 387-398, 2010.
41. S. Morita, K. Soda, R. Teraoka, S. Kitagawa, and T. Terada, "Specific and sensitive enzymaticmeasurement of sphingomyelin in cultured cells, " Chemistry and Physics of Lipids, vol. 165, no. 5, pp. 571-576, 2012.
42. S. Morita, T. Tsuda, M. Horikami, R. Teraoka, S. Kitagawa, and T. Terada, "Bile salt-stimulated phospholipid efflux mediated by ABCB4 localized in nonraft membranes, " Journal of Lipid Research, vol. 54, no. 5, pp. 1221-1230, 2013.
43. K. Nagao, Y. Zhao, K. Takahashi, Y. Kimura, and K. Ueda, "Sodium taurocholate-dependent lipid efflux by ABCA1: effects of W590S mutation on lipid translocation and apolipoprotein A-I dissociation, " Journal of Lipid Research, vol. 50, no. 6, pp. 1165-1172, 2009.
44. J. Gautherot, D. Delautier, M. A. Maubert et al., "Phosphorylation of ABCB4 impacts its function: insights from diseasecausing mutations, " Hepatology, 2014.
45. T. Yoshikado, T. Takada, T. Yamamoto et al., "Itraconazoleinduced cholestasis: Involvement of the inhibition of bile canalicular phospholipid translocator MDR3/ABCB4, " Molecular Pharmacology, vol. 79, no. 2, pp. 241-250, 2011.
46. K. Kino, Y. Taguchi, K. Yamada, T. Komano, and K. Ueda, "Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR1 and MDR2/P-glycoproteins, " FEBS Letters, vol. 399, no. 1-2, pp. 29-32, 1996.
47. Z. Duan, K. A. Brakora, and M. V. Seiden, "Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal resistance in human ovarian cancer cells, " Molecular Cancer Therapeutics, vol. 3, no. 7, pp. 833-838, 2004.
48. Z. E. Sauna and S. V. Ambudkar, "About a switch: how P-glycoprotein (ABCB1) harnesses the energy of ATP binding and hydrolysis to domechanical work, "Molecular CancerTherapeutics, vol. 6, no. 1, pp. 13-23, 2007.
49. M. Ishigami, Y. Tominaga, K. Nagao et al., "ATPase activity of nucleotide binding domains of human MDR3 in the context of MDR1, " Biochimica et Biophysica Acta, vol. 1831, no. 4, pp. 683-690, 2013.
50. Y. Ikebuchi, T. Takada, K. Ito et al., "Receptor for activated C-kinase 1 regulates the cellular localization and function of ABCB4, " Hepatology Research, vol. 39, no. 11, pp. 1091-1107, 2009.
51. J. Gautherot, A. Durand-Schneider, D. Delautier et al., "Effects of cellular, chemical, and pharmacological chaperones on the rescue of a trafficking-defectivemutant of the ATP-binding cassette transporter proteins ABCB1/ABCB4, " Journal of Biological Chemistry, vol. 287, no. 7, pp. 5070-5078, 2012.
52. E. J. and ress, M. Nicolaou, and M. R. Romero, "Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4, " Hepatology, vol. 59, no. 5, pp. 1921-1931, 2014.
53. R. Gordo-Gilart, S. andueza, L. Hierro et al., "Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity, " Gut, 2014.
54. S. Orlowski, S. Martin, and A. Escargueil, "P-glycoprotein and lipid rafts: Some ambiguousmutual relationships (floating on them, building them ormeeting them by chance?), " Cellular and Molecular Life Sciences, vol. 63, no. 9, pp. 1038-1059, 2006.
55. K. Klappe, I. Hummel, D. Hoekstra, and J. W. Kok, "Lipid dependence of ABC transporter localization and function, " Chemistry and Physics of Lipids, vol. 161, no. 2, pp. 57-64, 2009.
56. P. J. Quinn, "A lipid matrix model of membrane raft structure, " Progress in Lipid Research, vol. 49, no. 4, pp. 390-406, 2010.
57. J. L. Macdonald and L. J. Pike, "A simplifiedmethod for the preparation of detergent-free lipid rafts, " Journal of Lipid Research, vol. 46, no. 5, pp. 1061-1067, 2005.
58. E. Zaks-Makhina, H. Li, A. Grishin, V. Salvador-Recatala, and E. S. Levitan, "Specific and slow inhibition of the Kir2. 1K+channel by gambogic acid, "The Journal of Biological Chemistry, vol. 284, no. 23, pp. 15432-15438, 2009.
59. R. J. P. Dawson and K. P. Locher, "Structure of a bacterialmultidrug ABC transporter, " Nature, vol. 443, no. 7108, pp. 180-185, 2006.
60. S. G. Aller, J. Yu, A. Ward et al., "Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding, " Science, vol. 323, no. 5922, pp. 1718-1722, 2009.
61. D. A. P. Gutmann, A. Ward, I. L. Urbatsch, G. Chang, and H. W. van Veen, "Understand ing polyspecificity ofmultidrug ABC transporters: closing in on the gaps in ABCB1, " Trends in Biochemical Sciences, vol. 35, no. 1, pp. 36-42, 2010.
62. A. J. Smith, J. L. Timmermans-Hereijgers, B. Roelofsen et al., "The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice, " FEBS Letters, vol. 354, no. 3, pp. 263-266, 1994.
63. A. R. Crawford, A. J. Smith, V. C. Hatch, R. P. J. Oude Elferink, P. Borst, and J. M. Crawford, "Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 Pglycoprotein expression: visualization by electron microscopy, " Journal of Clinical Investigation, vol. 100, no. 10, pp. 2562-2567, 1997.
64. A. Groen, M. R. Romero, C. Kunne et al., "Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity, " Gastroenterology, vol. 141, no. 5, pp. 1927-1937, 2011.
65. P. Borst, N. Zelcer, and A. van Helvoort, "ABC transporters in lipid transport, " Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, vol. 1486, no. 1, pp. 128-144, 2000.